Altimmune Inc [NASDAQ: ALT] traded at a high on Wednesday, posting a 7.94 gain after which it closed the day’ session at $7.07.
The results of the trading session contributed to over 4110941 shares changing hands. Over the past one week, the price volatility of Altimmune Inc stands at 8.73% while the volatility over the past one month is 7.91%.
The market cap for ALT stock reached $501.26 million, with 70.68 million shares outstanding and 70.17 million shares in the current float. Compared to the average trading volume of 4.67M shares, ALT reached a trading volume of 4110941 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Altimmune Inc [ALT]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ALT shares is $21.86 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ALT stock is a recommendation set at 1.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Guggenheim have made an estimate for Altimmune Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on April 29, 2024. While these analysts kept the previous recommendation, Goldman raised their target price to Neutral. The new note on the price target was released on January 24, 2024, representing the official price target for Altimmune Inc stock. Previously, the target price had yet another drop from $20 to $6, while Goldman kept a Neutral rating on ALT stock.
The Average True Range (ATR) for Altimmune Inc is set at 0.71, with the Price to Sales ratio for ALT stock in the period of the last 12 months amounting to 1165.73. The Price to Book ratio for the last quarter was 2.57, with the Price to Cash per share for the same quarter was set at 2.79.
How has ALT stock performed recently?
Altimmune Inc [ALT] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -0.14. With this latest performance, ALT shares dropped by -24.43% in over the last four-week period, additionally plugging by 195.82% over the last 6 months – not to mention a rise of 43.70% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ALT stock in for the last two-week period is set at 41.56, with the RSI for the last a single of trading hit 43.29, and the three-weeks RSI is set at 42.29 for Altimmune Inc [ALT]. The present Moving Average for the last 50 days of trading for this stock 9.14, while it was recorded at 6.89 for the last single week of trading, and 6.06 for the last 200 days.
Altimmune Inc [ALT]: Deeper insight into the fundamentals
Altimmune Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 17.25 and a Current Ratio set at 17.25.
Insider trade positions for Altimmune Inc [ALT]
The top three institutional holders of ALT stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.4983%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $200.69 billion in ALT stocks shares; and BERKSHIRE HATHAWAY INC, currently with $174.35 billion in ALT stock with ownership which is approximately 5.8386%.
